HSE pays 47% more for 'brand name' drugs

A new survey has found that Ireland's Health Service is paying one-and-a-half times more than Britain for brand name medicines.

The study carried out for the Swedish pharmaceutical sector shows that Ireland pays more than any other Northern European country for drugs that are still under patent.

The survey found that the HSE pays 47% more than Britain's NHS for such "brand name" drugs.

Email Updates

Receive our lunchtime briefing straight to your inbox

More in this Section

Michael Noonan: Changes to US tax law will not adversely affect Ireland

NBRU will not attend talks with Bus Éireann today

People who eat seafood are consuming plastic

International Space Station to take call from Irish primary children


Today's Stories

Man made €6k selling ‘fake Adele tickets’

HSE Audit: Barnardos staff paid more than HSE rates

‘I had to break my silence of 20 years to protect others’

Woman sues husband for €77k over murder of their sons, aged 10 and 5

Lifestyle

Making cents: Shopping around is still the best way to save some cash

Reframing Michael Collins in The Big Fellow

It's been a long and winding road for music group Fairport Convention

We’ll have to shout ‘stop’ to non-bio plastics, or else...

More From The Irish Examiner